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INTERACTION OF  GLUCOCORTICOIDS 
WITH MACROPHAGES 
Identification  of Glucocorticoid  Receptors in Monocytes 
and Macrophages* 
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(From the Laboratory  of Radiobiology,  University  of California,  San Francisco,  California  94143, 
and the Departments  of Medicine  and Physiology,  Dartmouth Medical School,  Hanover,  New 
Hampshire 03755) 
The  mononuclear  phagocyte  system  plays  a  central  role  in  mediating  host 
responses in inflammation  (1).  Glucocorticoids have anti-inflammatory  actions 
that may be of considerable importance in the therapeutic effects of these agents 
in chronic inflammation;  it is possible that some of these effects are  mediated 
through direct hormonal action on macrophages.  Although the site of action of 
the glucocorticoids on macrophages has not been established,  it has been shown 
that  in  many other glucocorticoid target  systems the effects  of glucocorticoids 
are  mediated  by  specific  macromolecular  binding  proteins,  referred  to  as 
receptors (2-4). 
In this study we have established that monocytes and macrophages contain 
saturable  glucocorticoid-binding  proteins,  with  specificity  of binding for corti- 
sol,  corticosterone,  and related  synthetic  steroids such as dexamethasone,  and 
that they have dissociation constants for binding within physiological ranges. 
Materials and Methods 
Cell Culture.  Mouse peritoneal macrophages were harvested from female Swiss Webster mice 
~CD-1 and CF-1; Charles River Breeding Laboratories, Inc., Wilmington, Mass.) weighing 20-25 
g, as described previously (5, 6). Resident macrophages were obtained from unstimulated animals, 
and elicited macrophages were obtained from mice injected 4 days before with 1.0 ml of Brewer 
thioglycollate  medium  ~5,  6).  Cells  were  plated  at  0.5-1  ×  10  '~  cells/well  in  2-cm-'-diameter 
muhiwell plates  I Microbiological Associates,  Walkersville,  Md.)  in  Dulbecco~s  modified Eagle's 
medium  high  glucose  formulation  IDME~'  supplemented  with  10~  heat-inactivated fetal  calf 
serum  (FCS)IGrand Island Biological Co.,  Grand Island,  N.  Y.I.  1-24 h  before binding experi- 
ments, cells were placed in serum-free  DME  supplemented with 0.2~  lactalbumin hydrolysate 
DME-LH~. 
Rabbit  alveolar  macrophages  were  obtained  by  lung  lavage  10-14  days  after  intravenous 
* Supported  by  grants  AM  14780,  AM  03535,  and  CA  17323  from  the  U.  S.  Public  Health 
Service,  by  grants  from  the  National  Chapter  of the  Arthritis  Foundation  and  the  Dufault 
Bequest  for  Arthritis Research  administered by  the  New  Hampshire Chapter  of the  Arthritis 
Foundation, and by the U. S. Department of Energy. 
Abbreviations  used in this paper:  DME, Dulbecco's modified Eagle's medium; DME-LH,  DME 
supplemented  with  0.2%  lactalbumin  hydrolysate;  FCS,  fetal  calf serum;  Ka,  half-maximum 
saturation; KRPg,  Krebs-Ringer phosphate buffer containing 5.5 mM glucose. 
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injection of 0.15  ml of Freund's complete adjuvant (Difco Laboratories, Detroit,  Mich.) (7).  The 
cells were washed 3 times in Hanks' balanced salt solution and resuspended at 2-4  x  10e/ml  in 
DME-LH. The alveolar macrophages were then plated in multiwell dishes at 2 x  l0  s cells/well, or 
cultured in suspension for 3 h before use in the assays of steroid binding. Cells in suspension were 
centrifuged, washed in Hanks' balanced salt solution, and resuspended at cytocrits of 0.24-0.36 
for binding experiments. 
Human  monocytes were isolated from 300  ml of freshly drawn, citrated blood.  Mononuclear 
cells were concentrated by Ficoll-Hypaque fractionation (8), washed twice in RPMI-1640 medium 
(Grand Island Biological Co.),  and resuspended at 1  x  10' cells/ml in RPMI-1640 supplemented 
with 10% autologous serum. Cells were plated in multiwell plates precoated with 10 ~g of fibrin/ 
cm  ~ to aid adherence of monocytes. Nonradioactive fibrin layers were prepared by the procedure 
used for '25I-labeled fibrin layers (9).  After 16  h  at 37°C in a  CO2  incubator,  nonadherent cells 
were removed by washing, and adherent cells were placed in serum-free DME-LH for 2 h before 
measurement of receptors. The mean purity of the monocyte preparation was 93%. 
Cells  were  counted  in  a  Coulter  counter  (Coulter  Electronics  Inc.,  Hialeah,  Fla.),  and 
differential cell counts were made on cytocentrifuge preparations stained with Wright's stain. 
Steroid Binding 
MEASUREMENT OF STEROID ROUND TO RECEPTORS  IN  INTACT CELLS.  Monolayers of macrophages 
in 2-cm~-diameter wells were washed rapidly 3 times at room temperature with ~2 ml of Krebs- 
Ringer phosphate buffer containing 5.5 mM glucose (KRPg). Each well then received 100-200  ftl 
of KRPg containing [1,2,4-3H  (N)]dexamethasone or [6,7-3H(N)]dexamethasone INew England 
Nuclear,  Boston,  Mass.;  30-50  Ci/mmol}.  In  a  few  experiments,  [1,2,3-3H(n)]triamcinolone 
acetonide  (New  England  Nuclear;  45  Ci/mmol) was  used  instead of [3H]dexamethasene. The 
plates were incubated at 37°C for 70 rain, then placed on ice. Aliquots of medium from each well 
were taken to determine the concentration of free [3H]dexamethasone. Each well was rinsed 6 
times  with  2  ml  of ice-cold KRPg  to  remove  free  steroid,  and  then  left  for  20  min  at  room 
temperature with buffer. The treatment at room temperature removed most of the nonsaturable 
fraction of cell-associated steroid, as previously shown for thymus cells (10,  11). The remaining 
steroid was extracted with 150  ~tl  of ethanol at room temperature for 20  min,  followed by  an 
additional 50 ~1 to rinse the wells. Samples were counted in Bray's fluid (New England Nuclear) 
in a  Packard Tri-Carb liquid scintillation spectrometer (Packard Instrument Co., Inc., Downers 
Grove,  Ill.).  Data  were  analyzed by  conventional plots of bound  versus  free  steroid,  and  by 
Scatchard plots separated by trial and error into saturable and nonsaturable components (12, 13). 
Protein content of monolayers was  determined in  sham-treated wells which had  not been 
extracted with ethanol, and on residual cellular protein after ethanol extraction by selubilization 
in  0.5  M  NaOH  followed by  Lowry-Folin procedure with crystalline bovine serum albumin as 
standard (14). 
COMPETITIVE BINDING STUDIES.  Competition for binding with whole cells was carried out as 
for  binding  of  [3H]dexamethasone  alone,  except  that  the  incubation  media  contained  both 
[3H]dexamethasone  and  the  unlabeled  competing steroid  at  the  concentrations indicated  in 
Results.  Cortisol  and  other  steroids of similar  solubility were dissolved in  KRPg,  and  their 
concentration was determined spectrophotometrically by  measuring adsorption at  250  nm and 
assuming E =  1.4  ×  l0  t M-' cm -1  (11). Less soluble steroids such as estradiol were dissolved in 
ethanol;  incubations  for  these  steroids  contained  up  to  1~  ethanol,  which  did  not  affect 
dexamethasone binding.  Steroids were obtained from  Steraloids, Inc.,  Pawling,  N.  Y.,  Calbi- 
ochem, San Diego, Calif., or Sigma Chemical Co., St. Louis, Mo. 
DEXAMETHASONE BINDING TO ~CYTOPLASMIC" AND NUCLEAR FORMS OF GLUCOCORTICOID RECEPTORS 
AND TEMPERATURE-SENSITIVE TRANSLOCATION FROM ~CYTOPLASMIC" TO NUCLEAR FORMS.  Thioglycol- 
late-elicited macrophages were  either  washed out  of the  peritoneal cavity  of mice  and  used 
directly, or cultured for 24 h  in 100-ram-diameter tissue culture dishes as described above, and 
scraped off the surface with a rubber policeman before use. The cells were sedimented and washed 
three times with KRPg at room temperature, and finally incubated at a cytocrit of 0.33 ml packed 
cells/ml of suspension with [3H]dexamethasone in the absence or presence of 500 nM unlabeled 
dexamethasone.  The  values  obtained  in  the  presence of unlabeled  dexamethasone were  for 
nonsaturable binding. The cells were incubated at 3°C for 120 min, then at 37°C for 30 min. After 
both  incubations,  the  cells  in  duplicate  20-ttl  aliquots  of the  suspensions were  disrupted  by 1686  MACROPHAGE  GLUCOCORTICOID  RECEPTORS 
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Fro.  1.  Time course of binding of dexamethasone to glucocorticoid receptors in thioglycol- 
late-elicited  mouse  peritoneal  macrophages.  Binding  to  cells  was  with  2.8  nM 
[ZH]dexamethasone. Only saturable binding is shown. The nonsaturable component deter- 
mined in  the presence of added cold  dexamethasone (1,000  nM)  was  <20%  of the  total 
binding. Results are expressed as mean -+ SD, n  =  3. 
hypotonic  shock  in  1.5  mM  MgCl~  to  determine  "cytoplasmic"  and  nuclear  binding  by  a 
modification of the charcoal absorption and nuclear pellet procedures developed for lymphocytes 
(10,  15). A modification consisting of a  freeze-thaw (freezing in acetone-dry ice, thawing at 3°C1 
after addition of the cells to MgCl~ was necessary to break open the macrophages. Values were 
expressed  as  the  mean  -+  SD  for  saturable  binding,  obtained  by  subtracting  the  mean  for 
nonsaturabte binding at 4 nM [:~H]dexamethasone. 
Results 
Physicochemical Interactions of Dexamethasone with Thioglycollate-Elicited 
Mouse  Peritoneal  Macrophages.  Specific  binding  of  [:~H]dexamethasone  to 
monolayers of thioglycollate-elicited mouse peritoneal macrophages increased 
rapidly for 30  min at 37°C, and then reached a  plateau  (Fig.  1).  The rate  of 
binding at  3°C  was  slower  (not  shown).  Binding could be  resolved  into two 
components:  a  high  affinity component,  which  was  saturable  and  could  be 
displaced by excess nonradioactive steroid, and a low affinity component, which 
was not saturated up to 100 nM dexamethasone and was not displaced by excess 
nonradioactive steroid (Fig. 2). The high affinity binding had a half-maximum 
saturation  (Kd)  at  3.7  nM  dexamethasone.  High  affinity binding  was  not 
influenced by  the  prolonged  washing procedures  used,  whereas  low  affinity 
(nonsaturable)  binding  usually  decreased  to  <20%  of the  total  binding  of 
radioactive  hormone;  the  20-min  room  temperature  wash  was  particularly 
useful in decreasing nonsaturable binding. High affinity binding was ~  80-100 
fmol of dexamethasone/mg cell protein (3,500-6,000  binding sites/cell) (Table I). 
Binding was enhanced by  =20%  when the  macrophages were  removed  from 
DME + FCS and placed in DME-LH at least I h before experiments for hormone 
binding. High affinity binding did not increase further with culture of the cells 
in DME-LH for up to 72 h. The number and avidity of the hormone receptors 
did not change with time.  High affinity binding was the same when macro- 
phages that  had been  explanted  1,  24,  72,  or  144  h  were used.  Binding was 
proportional to the number of macrophages adhering to the plate. Only viable 
cells  bound  the  steroid;  macrophages  killed  by  heat  or  acid  did  not  bind 
dexamethasone. =E 
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Fro.  2.  [SH]dexamethasone binding of thioglycollate-elicited macrophages.  The binding 
of dexamethasone to intact cells in monolayer at 37°C was made as described in Materials 
and Methods. The results of a  typical experiment are shown as a  Scatchard plot analyzed 
into saturable (  ) and nonsaturable (- -  -) components,  and as a  conventional plot of 
bound vs. free dexamethasone (inset). The parameters of the solid lines are: slope = -K, 
=  0.27  (nM)  1,  intercept  =  3,500  sites/cell.  The  line  (...)  gives  the  sum  of  the  two 
components.  Original data  are  shown by  (O)  and original data  after subtraction of the 
nonsaturable component are shown by (©). 
TABLE  I 
Characteristics of Glucocorticoid Receptors in Cultured Mononuclear Phagocytes 
Source  Species 
Receptors 
fmol/mg of  Sites/cell  Kd  [3H]Labeled ligand  cell protein 
nM 
Blood monocytes  Human  Dexamethasone  470  9,000  7.7 
Resident peritoneal  Mouse  Triamcinolone  270  6,100  2.1 
macrophages  acetonide 
Exudative perito-  Mouse  Dexamethasone  80  4,300  3.7 
neal macrophages 
P388D1 cells  Mouse  Dexamethasone  65  4,200  4.0 
Induced alveolar  Rabbit  Triamcinolone  3,800*  4,500  2.6 
macrophages  acetonide 
Dexamethasone  85  4,600  1.8 
* fmol/ml packed cells. 1688  MACROPHAGE  GLUCOCORTICOID  RECEPTORS 
TABLE II 
Competition by Various Steroids for Binding of 
[3H]Dexamethasone to Glucocorticoid Receptors in Plated 
Thioglycollate-Elicited  Mouse Macrophages 
[~H]Dexamethasone 
Competing steroid  Concentration 
binding* 
nM  ~  control 
Dexamethasone  1,000  18  ±  1 
Cortisol  100  77  ±  1 
1,000  33  ±  1 
Corticosterone  100  84  ±  6 
1,000  40  ±  2 
Cortexolone  90  92  ±  3 
900  56  ±  2 
Progesterone  120  93  ±  3 
1,200  54  ±  3 
Cortisone  1,000  81  ±  2 
11-Epicortisol  1,000  105 
Estradiol  100  98  ±  8 
1,000  96  ±  10 
Dihydrotestosterone  100  101  ±  15 
1,000  85  +  11 
Testosterone  85  85  ±  10 
850  78  ±  3 
* Whole  cell  binding  assay;  values  are  shown  as  mean  ±  range. 
[~H]Dexamethasone was present in the assay at 8 nM. 
The binding of dexamethasone to the thioglycollate-elicited macrophages was 
specific for glucocorticoids. As shown in Table II, dexamethasone,  cortisol, and 
corticosterone  competed for  receptor-bound  [3H]dexamethasone.  Progesterone 
and cortexolone also competed for receptors. These substances sometimes act as 
antiglucocorticoids (4). Cortisone had a small but reproducible competing effect 
in macrophages,  and  it  is possible that  some limited  metabolic conversion  to 
cortisol may have occurred. Estradiol,  ll-epicortisol, testosterone, and dihydro- 
testosterone did not compete for binding. 
In many other glucocorticoid-responsive systems, the hormone effect depends 
upon glucocorticoid binding to a receptor protein in the "cytoplasm" followed by 
intracellular  transport  into the nucleus (4).  In a  modified cytosol and nuclear- 
pellet preparation  at 3°C, the receptor-bound dexamethasone in thioglycollate- 
elicited macrophages was largely found in a  soluble "cytoplasmic" form, which 
was rapidly transferred to a nuclear form when the temperature was raised to 
37°C (Fig.  3). Thus, these results support the presence of a  functional receptor 
system for dexamethasone in elicited mouse macrophages. 
Glucocorticoid  Receptors  in  Resident  Mouse  Peritoneal  Macro- 
phages.  Macrophages normally residing in the peritoneal cavity of mice also 
bound glucocorticoids with high affinity (for triamcinolone acetonide, I4~ =  2.1 
nM) and contained  ---6,000 sites/cell  (Table I).  As in elicited peritoneal  macro- 
phages,  steroids  with  glucocorticoid  activity  (triamcinolone  acetonide  and 
dexamethasone) and progesterone competed with dexamethasone for binding to 
receptors (Table III). ZENA  WERB,  ROSEMARY  FOLEY,  AND  ALLAN  MUNCK  1689 
lo,oooi 
o 
5,00C 
-.-.-  -  - 
//I/I 
///// 
I//I/ 
Cytoplasmic 
Incubation at 
:3"C  57"C 
Nuclear 
//Y// 
11111 
////I 
I///I 
i/n.~'l  II//1 
//2"/,  /  /  /  /  / 
/////  ///// 
"'"  "/'///5  IIII/ 
iiii  I  Illll 
v/l/. 
Cytoplasm)c  Nuclear 
FIG. 3.  Dexamethasone  binding  to  "cytoplasmic"  and  nuclear  forms  of glucocorticoid 
receptors in thioglycollate-elicited  mouse peritoneal macrophages  and temperature-sensi- 
tive translocation from "cytoplasmic"  to nuclear forms.  Cell suspensions  were incubated 
with [3H]dexamethasone as described in Materials and Methods. Saturable binding sites in 
"cytoplasmic" fractions and nuclear pellets for cells incubated  at 3°C for 120 min are shown 
on the left; sites for cells incubated at 3°C for 120 min followed by 37°C for 30 min are shown 
on  the  right.  Values  are  expressed  as  mean and  range obtained for binding  at  4 nM 
[~H]dexamethasone. 
Mouse Macrophages from Other Sources.  High affinity saturable binding of 
glucocorticoids  to  macrophages  elicited  in  the  peritoneal  cavity  by  pristane 
(data  not  shown),  resident  lung  macrophages  (data  not  shown),  and  P388D1 
cells from a  macrophage-like continuous line s (Table I) was also demonstrated. 
Rabbit Alveolar Macrophages.  Pulmonary  alveolar macrophages obtained 
from  rabbits  2  wk  after  intravenous  injection  of complete  Freund's  adjuvant 
bound  dexamethasone  and  triamcinolone  acetonide  to  high  affinity  receptor 
sites  (Table I). Cells adhering to plastic surfaces and cells in suspension bound 
the  glucocorticoid  equally  well.  The number  and  affinity of the  rabbit  macro- 
phage  glucocorticoid receptors were similar to that observed for mouse macro- 
phages.  For  optimal  binding,  the  macrophages  were  cultured  in  serum-free 
DME-LH  for  2-24  h  after  removal  from  the  lungs.  Dexamethasone  bound 
specifically to receptors with high affinity for glucocorticoids.  As shown in Fig. 
4,  dexamethasone,  triamcinolone acetonide,  and hydrocortisone competed with 
[3H]dexamethasone  for binding  to receptors,  whereas  cortisone,  estradiol,  and 
dihydrotestosterone did not. 
Human  Blood  Monocytes.  The  rabbit  and  the  mouse  are  glucocorticoid- 
sensitive species,  whereas  man is relatively glucocorticoid resistant  (2).  It was 
thus  of particular  interest  to  examine  the  glucocorticoid  receptors  in  human 
mononuclear  phagocytes.  Blood  monocytes in  monolayer culture  bound  dexa- 
methasone  (Fig.  5).  The  high  affinity  component  was saturated  by 30  min  of 
incubation  at 37°C  with  10 nM dexamethasone,  and it had a  K~l of ~7 nM.  The 
low  affinity component  was  nonsaturable.  The  human  monocytes had  ~9,000 
-' Werb, Z., R. Foley, and A. Munck. 1978. Glucocorticoid receptors and glucocorticoid-sensitive 
secretion of neutral proteinases in a macrophage line. J. Immunol. In press. 1690  MACROPHAGE  GLUCOCORTICOID  RECEPTORS 
TABLE  III 
Competition  by Various Steroids for Binding of 
[3H]Dexamethasone to Glucocorticoid Receptors in Resident 
Mouse Peritoneal Macrophages 
[3H]Dexamethasone 
Competing steroid  Concentration  binding* 
nM  % control 
None  -  100 ± 3 
Triamcinolone acetonide  10  34 -+ 0 
100  29 _+ 1 
Dexamethasone  100  32 ±  1 
1,000  18 z  1 
Cortisol  100  63 +- 12 
1,000  30 ±  8 
Cortisone  1,000  82 _+ 6 
Progesterone  100  73 -+ 6 
1,000  38 ±  9 
ll-Epicortisol  1,000  107 -+ 8 
Dihydrotestosterone  1,000  100 ±  2 
Estradiol  1,000  93 -+ 4 
* Whole  cell  binding  assay  with  [3H]dexamethasone  present  in  the 
assay at 3 nM; values are shown as mean _+ SD of triplicates. 
r 
"~'  20 
O 
i  i  i  i 
0  1  10  1  O0  1,000 
Competing Steroid Conc (nM) 
FZG.  4.  Competition by various steroids for binding to glucocorticoid receptors in adherent 
rabbit alveolar macrophages.  Competition for binding of [3H]dexamethasone at 10 nM was 
tested  with dexamethasone  IO}, triamcinolone acetonide  I©), cortisol  (E3~, cortisone  (A), 
estradiol  (~7), and dihydrotestosterone  (T).  Results are expressed as mean  +_  SD,  n  =  3. 
Conc, concentration. 
sites/cell  (Table  I),  well  within  the  range  for  rabbits  and  mice.  There  were 
reproducibly  more  glucocorticoid  receptors  in  blood  monocytes  than  in  the 
lymphocytes  isolated  from  the  same  preparations  (--=3,000  sites/cell),  and 
platelets  contaminating  the  monocyte  preparations  contained  no demonstrable 
receptors  (G.  Crabtree,  K.  Smith,  and  A.  Munck,  unpublished  observations). 
Cortisol  and  dexamethasone  competed  for binding  of [3H]dexamethasone  to the 
monocytes,  whereas  steroids  without  glucocorticoid activity  did not  (Table  IV). A 
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[3H]dexamethasone binding to  monolayers of human  monocytes.  Scatchard  and 
conventional (inset) plots of bound vs. free dexamethasone are used to determine saturable 
and nonsaturable components. For details, see Fig.  2.  The solid line parameters are: slope 
=  -Ka  =  0.13 (nM) -1, intercept  =  9,000 sites/cell. 
TABLE  IV 
Competition  by Various Steroids for Binding of 
[3H]Dexamethasone to Glucocorticoid Receptors in Human 
Monocytes 
['~H]Dexamethasone 
Competing steroid  Concentration 
binding* 
nM  ~ control 
Dexamethasone  1,000  22 _+ 3 
Cortisol  1,000  59  -+ 3 
Cortisone  1,000  95  -+ 3 
ll-Epicortisol  1,000  118  -+ 9 
* Whole  cell  binding  assay;  values  are  shown  as  mean  -+  SD. 
[:~H]Dexamethasone was present in the assay at 8 nM. 
Thus,  the monocyte contained specific  binding sites consistent with glucocorti- 
coid action at physiological concentrations. 
Discussion 
The  studies  reported  here  show  that  glucocorticoid  receptors  are  present  in 
intact mononuclear phagocytes  from mouse,  rabbit,  and man.  The dissociation 
constants  found  (Table  I)  were  ~-2-8  nM  for  dexamethasone;  the  competition 
for  binding  by  cortisol  at  about  10-fold  higher  concentrations  suggests  that 1692  MACROPHAGE  GLUCOCORTICOID  RECEPTORS 
glucocorticoid receptor-mediated functions in macrophages would be operative 
at physiological concentrations. 
The  number  of receptor  sites  and  their  affinity were  similar  for  resident 
macrophages, macrophages elicited by inflammatory stimuli, and blood mono- 
cytes,  and  they were  similar to  those reported  for lymphoid cells  (3,  4,  16}. 
Although unstimulated monocytes and macrophages had higher concentrations 
of steroid receptors  than  did elicited macrophages,  this  does  not  necessarily 
signify a  difference in sensitivity to glucocorticoid action.  Mitogen-stimulated 
lymphocytes contain several times more receptors than unstimulated lympho- 
cytes, and yet both populations are equally steroid sensitive (16). 
In the present study, glucocorticoid binding was examined with dexametha- 
sone and triamcinolone acetonide as the ligands. These synthetic glucocorticoids 
have the advantage of not binding to transcortin, a  serum protein that binds 
cortisol (17); thus, accurate glucocorticoid concentrations could be determined. 
Also, experiments were made in the absence of serum to decrease interference 
from exogenous steroids.  Serum cortisol and progesterone both compete with 
dexamethasone for binding, and could influence the free steroid concentrations 
present in the experiments. 
In other work we have shown that P388D1 macrophages, a  continuous cell 
line,  contain glucocorticoid receptors  indistinguishable from those  of normal 
mouse macrophages.'-' We have demonstrated temperature-sensitive transfer of 
glucocorticoid receptors to macrophage nuclei. With P388D1 cells we have been 
able  to  demonstrate glucocorticoid binding directly to  proteins  isolated from 
cytoplasm, temperature-dependent activation of the hormone-receptor complex, 
and translocation of only activated complexes into isolated nuclei.  ~ 
In virtually every target tissue investigated, the first step in steroid hormone 
action  is  the  binding  of steroid  to  specific  receptor  proteins.  Because  their 
specificity and affinity correlate with biological functions, they may mediate 
the hormone action. Some effects of glucocorticoids on macrophages have been 
described previously; in most experiments, however, pharmacological concen- 
trations of steroids were used (2,  18). These effects are unlikely to be mediated 
by  the  high affinity receptors  described  in  this  paper.  In  the  accompanying 
paper (18) hormone effects at glucocorticoid concentrations similar in specificity 
and  affinity to  those  for  receptor  characteristics  are  shown  for  macrophage 
secretion and growth. 
Summary 
Glucocorticoid binding was measured in resident and thioglycollate-elicited 
mouse  peritoneal  macrophages,  rabbit  alveolar  macrophages,  and  human 
monocytes. Two  assays of binding were  used-an  assay with  intact  cells  in 
suspension  or  monolayers,  and  an  assay  of cytosol  and  nuclear  forms  of 
glucocorticoid receptors.  The mononuclear phagocytes contained  24-10  ×  10  :~ 
high affinity receptor  sites  per  cell,  with dissociation constants of ~2-8  nM 
dexamethasone. The binding to the saturable sites was specific for steroids with 
glucocorticoid or  antiglucocorticoid activity. Cortisol,  corticosterone,  and  pro- 
gesterone competed with dexamethasone for binding, whereas estradiol, dihy- 
drotestosterone, and ll-epicortisol competed very little. ZENA  WERB,  ROSEMARY  FOLEY,  AND  ALLAN  MUNCK  1693 
Binding  of  dexamethasone  to  cytosol  and  nuclear  forms  of  the  receptor 
complex  and  temperature-sensitive  translocation  of cytosol forms  to  nuclear 
forms  were  shown.  At  37°C  the  predominant  form  of the  hormone-receptor 
complex was  nuclear.  These  results  demonstrate  that  corticosteroids  interact 
with macrophages at physiological concentrations. 
We thank Ms. I. Vander Heiden and Ms. Nancy Cidlowski for their technical assistance.  These 
studies were initiated  while Z. W. was a visiting professor in the laboratory of Dr. E. D. Harris, 
Jr., Dartmouth Medical School. 
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